{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:40:13Z","timestamp":1786981213061,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,7,27]],"date-time":"2014-07-27T00:00:00Z","timestamp":1406419200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s10875-014-0079-3","type":"journal-article","created":{"date-parts":[[2014,7,25]],"date-time":"2014-07-25T22:35:44Z","timestamp":1406327744000},"page":"820-827","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Infliximab for Treatment of Granulomatous Disease in Patients with Common Variable Immunodeficiency"],"prefix":"10.1007","volume":"34","author":[{"given":"Timothy J.","family":"Franxman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Howe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"James R.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,27]]},"reference":[{"issue":"3","key":"79_CR1","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1006\/clim.1999.4799","volume":"93","author":"ME Conley","year":"1999","unstructured":"Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol. 1999;93(3):190\u20137.","journal-title":"Clin Immunol"},{"issue":"5","key":"79_CR2","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s11882-005-0008-x","volume":"5","author":"Y Morimoto","year":"2005","unstructured":"Morimoto Y, Routes JM. Granulomatous disease in common variable immunodeficiency. Curr Allergy Asthma Rep. 2005;5(5):370\u20135.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1","key":"79_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1182\/blood-2010-01-254417","volume":"116","author":"C Cunningham-Rundles","year":"2010","unstructured":"Cunningham-Rundles C. How I, treat common variable immune deficiency. Blood. 2010;116(1):7\u201315.","journal-title":"Blood"},{"issue":"2","key":"79_CR4","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.clim.2009.05.001","volume":"133","author":"O Ardeniz","year":"2009","unstructured":"Ardeniz O, Cunningham-Rundles C. Granulomatous disease in common variable immunodeficiency. Clin Immunol. 2009;133(2):198\u2013207.","journal-title":"Clin Immunol"},{"issue":"12","key":"79_CR5","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.4049\/jimmunol.159.12.6236","volume":"159","author":"CG Mullighan","year":"1997","unstructured":"Mullighan CG, Fanning GC, Chapel HM, Welsh KI. TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease. J Immunol. 1997;159(12):6236\u201341.","journal-title":"J Immunol"},{"issue":"1","key":"79_CR6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s10875-012-9778-9","volume":"33","author":"JN Boursiquot","year":"2013","unstructured":"Boursiquot JN, Gerard L, Malphettes M, Fieschi C, Galicier L, Boutboul D, et al. Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients. J Clin Immunol. 2013;33(1):84\u201395.","journal-title":"J Clin Immunol"},{"issue":"8 Pt 1","key":"79_CR7","doi-asserted-by":"publisher","first-page":"613","DOI":"10.7326\/0003-4819-127-8_Part_1-199710150-00005","volume":"127","author":"LJ Mechanic","year":"1997","unstructured":"Mechanic LJ, Dikman S, Cunningham-Rundles C. Granulomatous disease in common variable immunodeficiency. Ann Intern Med. 1997;127(8 Pt 1):613\u20137.","journal-title":"Ann Intern Med"},{"issue":"6","key":"79_CR8","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/00007611-200006000-00023","volume":"93","author":"N Kanathur","year":"2000","unstructured":"Kanathur N, Byrd Jr RP, Fields CL, Roy TM. Noncaseating granulomatous disease in common variable immunodeficiency. South Med J. 2000;93(6):631\u20133.","journal-title":"South Med J"},{"issue":"3","key":"79_CR9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S1081-1206(10)61228-8","volume":"95","author":"A Thatayatikom","year":"2005","unstructured":"Thatayatikom A, Thatayatikom S, White AJ. Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature. Ann Allergy Asthma Immunol. 2005;95(3):293\u2013300.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"9","key":"79_CR10","doi-asserted-by":"publisher","first-page":"4620","DOI":"10.4049\/jimmunol.168.9.4620","volume":"168","author":"DR Roach","year":"2002","unstructured":"Roach DR, Bean AG, Demangel C, France MP, Briscoe H, Britton WJ. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol. 2002;168(9):4620\u20137.","journal-title":"J Immunol"},{"issue":"2","key":"79_CR11","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1182\/blood.V87.2.674.bloodjournal872674","volume":"87","author":"P Aukrust","year":"1996","unstructured":"Aukrust P, Lien E, Kristoffersen AK, Muller F, Haug CJ, Espevik T, et al. Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency\u2013possible immunologic and clinical consequences. Blood. 1996;87(2):674\u201381.","journal-title":"Blood"},{"issue":"4","key":"79_CR12","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.jaci.2006.01.034","volume":"117","author":"JH Lin","year":"2006","unstructured":"Lin JH, Liebhaber M, Roberts RL, Dyer Z, Stiehm ER. Etanercept treatment of cutaneous granulomas in common variable immunodeficiency. J Allergy Clin Immunol. 2006;117(4):878\u201382.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"79_CR13","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.clim.2009.11.014","volume":"134","author":"A Malbran","year":"2010","unstructured":"Malbran A, Juri MC, Fernandez Romero DS. Common variable immunodeficiency and granulomatosis treated with infliximab. Clin Immunol. 2010;134(3):359\u201360.","journal-title":"Clin Immunol"},{"issue":"2","key":"79_CR14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jaci.2004.05.057","volume":"114","author":"CA Bates","year":"2004","unstructured":"Bates CA, Ellison MC, Lynch DA, Cool CD, Brown KK, Routes JM. Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency. J Allergy Clin Immunol. 2004;114(2):415\u201321.","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"79_CR15","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","volume":"119","author":"ES Resnick","year":"2012","unstructured":"Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119(7):1650\u20137.","journal-title":"Blood"},{"issue":"1","key":"79_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s10875-012-9755-3","volume":"33","author":"NM Chase","year":"2013","unstructured":"Chase NM, Verbsky JW, Hintermeyer MK, Waukau JK, Tomita-Mitchell A, Casper JT, et al. Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID). J Clin Immunol. 2013;33(1):30\u20139.","journal-title":"J Clin Immunol"},{"issue":"5","key":"79_CR17","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.jaci.2005.08.041","volume":"116","author":"AZ Hatab","year":"2005","unstructured":"Hatab AZ, Ballas ZK. Caseating granulomatous disease in common variable immunodeficiency treated with infliximab. J Allergy Clin Immunol. 2005;116(5):1161\u20132.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"79_CR18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1046\/j.1365-2133.2001.04092.x","volume":"144","author":"KJ Smith","year":"2001","unstructured":"Smith KJ, Skelton H. Common variable immunodeficiency treated with a recombinant human IgG, tumour necrosis factor-alpha receptor fusion protein. Br J Dermatol. 2001;144(3):597\u2013600.","journal-title":"Br J Dermatol"},{"issue":"1\u20132","key":"79_CR19","first-page":"27","volume":"47","author":"E Douni","year":"1995\u20131996","unstructured":"Douni E, Akassoglou K, Alexopoulou L, Georgopoulos S, Haralambous S, Hill S, et al. Transgenic and knockout analyses of the role of TNF in immune regulation and disease pathogenesis. J Inflamm. 1995\u20131996;47(1\u20132):27\u201338.","journal-title":"J Inflamm"},{"issue":"5","key":"79_CR20","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1136\/jcp.47.5.423","volume":"47","author":"N Myatt","year":"1994","unstructured":"Myatt N, Coghill G, Morrison K, Jones D, Cree IA. Detection of tumour necrosis factor alpha in sarcoidosis and tuberculosis granulomas using in situ hybridisation. J Clin Pathol. 1994;47(5):423\u20136.","journal-title":"J Clin Pathol"},{"issue":"10","key":"79_CR21","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.4049\/jimmunol.151.10.5461","volume":"151","author":"AL Joseph","year":"1993","unstructured":"Joseph AL, Boros DL. Tumor necrosis factor plays a role in Schistosoma mansoni egg-induced granulomatous inflammation. J Immunol. 1993;151(10):5461\u201371.","journal-title":"J Immunol"},{"issue":"3","key":"79_CR22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1006\/clin.1994.1032","volume":"70","author":"P Aukrust","year":"1994","unstructured":"Aukrust P, Muller F, Froland SS. Elevated serum levels of interleukin-4 and interleukin-6 in patients with common variable immunodeficiency (CVI) are associated with chronic immune activation and low numbers of CD4+ lymphocytes. Clin Immunol Immunopathol. 1994;70(3):217\u201324.","journal-title":"Clin Immunol Immunopathol"},{"issue":"2","key":"79_CR23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1365-2249.1991.tb05805.x","volume":"86","author":"ME North","year":"1991","unstructured":"North ME, Spickett GP, Webster AD, Farrant J. Raised serum levels of CD8, CD25 and beta 2-microglobulin in common variable immunodeficiency. Clin Exp Immunol. 1991;86(2):252\u20135.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"79_CR24","first-page":"20","volume":"76","author":"E Girardin","year":"1992","unstructured":"Girardin E, Roux-Lombard P, Grau GE, Suter P, Gallati H, Dayer JM. Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. The J5 study group. Immunology. 1992;76(1):20\u20133.","journal-title":"Immunology"},{"issue":"2","key":"79_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000338179","volume":"128","author":"A Flammiger","year":"2012","unstructured":"Flammiger A, Fiedler W, Bacher U, Bokemeyer C, Schneider M, Binder M. Critical imbalance of TNF-alpha and soluble TNF receptor 1 in a patient with macrophage activation syndrome: potential implications for diagnostics and treatment. Acta Haematol. 2012;128(2):69\u201372.","journal-title":"Acta Haematol"},{"issue":"2","key":"79_CR26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jlb.64.2.135","volume":"64","author":"ML Heaney","year":"1998","unstructured":"Heaney ML, Golde DW. Soluble receptors in human disease. J Leukoc Biol. 1998;64(2):135\u201346.","journal-title":"J Leukoc Biol"},{"issue":"2","key":"79_CR27","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1124\/jpet.301.2.418","volume":"301","author":"B Scallon","year":"2002","unstructured":"Scallon B, Cai A, Solowski N, Rosenberg A, Song XY, Shealy D, et al. Binding and functional comparisons of two types of tumor necrosis factor antagonists. J Pharmacol Exp Ther. 2002;301(2):418\u201326.","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 3","key":"79_CR28","doi-asserted-by":"publisher","first-page":"S199","DOI":"10.1086\/429998","volume":"41","author":"S Ehlers","year":"2005","unstructured":"Ehlers S. Tumor necrosis factor and its blockade in granulomatous infections: differential modes of action of infliximab and etanercept? Clin Infect Dis. 2005;41 Suppl 3:S199\u2013203.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"79_CR29","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.4049\/jimmunol.1103298","volume":"188","author":"M Fallahi-Sichani","year":"2012","unstructured":"Fallahi-Sichani M, Flynn JL, Linderman JJ, Kirschner DE. Differential risk of ctuberculosis reactivation among anti-TNF therapies is due to drug bindingckinetics and permeability. J Immunol. 2012;188(7):3169\u201378.","journal-title":"J Immunol"},{"issue":"5","key":"79_CR30","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1002\/art.23447","volume":"58","author":"H Mitoma","year":"2008","unstructured":"Mitoma H, Horiuchi T, Tsukamoto H, Tamimoto Y, Kimoto Y, Uchino A, et al. Mechanisms for cytotoxic effects of anti-tumor necrosis factor agents on transmembrane tumor necrosis factor alpha-expressing cells: comparison among infliximab, etanercept, and adalimumab. Arthritis Rheum. 2008;58(5):1248\u201357.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"79_CR31","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/ng1600","volume":"37","author":"U Salzer","year":"2005","unstructured":"Salzer U, Chapel HM, Webster AD, Pan-Hammarstrom Q, Schmitt-Graeff A, Schlesier M, et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet. 2005;37(8):820\u20138.","journal-title":"Nat Genet"},{"issue":"8","key":"79_CR32","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/ng1601","volume":"37","author":"E Castigli","year":"2005","unstructured":"Castigli E, Wilson SA, Garibyan L, Rachid R, Bonilla F, Schneider L, et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet. 2005;37(8):829\u201334.","journal-title":"Nat Genet"},{"issue":"9","key":"79_CR33","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1182\/blood-2008-02-141937","volume":"113","author":"U Salzer","year":"2009","unstructured":"Salzer U, Bacchelli C, Buckridge S, Pan-Hammarstrom Q, Jennings S, Lougaris V, et al. Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood. 2009;113(9):1967\u201376.","journal-title":"Blood"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-014-0079-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-014-0079-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-014-0079-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-014-0079-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T10:05:58Z","timestamp":1689415558000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-014-0079-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,27]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["79"],"URL":"https:\/\/doi.org\/10.1007\/s10875-014-0079-3","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,27]]},"assertion":[{"value":"28 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}